A61K6/00

<i>Streptococcus mutans </i>glucosyl transferase inhibitors for dental caries therapy

The present invention is related to the inhibition of the formation of Streptococci biofilms through the inhibition of glucosyl transferase (Gtf). Compounds, compositions and methods for inhibiting Streptococcus biofilm formation, as well as for preventing, inhibiting and/or treating the formation of dental caries, and methods of identifying compounds that prevent, inhibit and/or treat the formation of dental caries are provided.

Rechargeable calcium phosphate-containing dental materials

The present invention provides rechargeable dental materials that can be widely applied in a variety of dental applications. The rechargeable dental materials of the invention may be included in dental primers, dental adhesives, dental resins, dental composites, dental bonding systems and the like, as well as dental cements, dental sealants, dental bases and dental liners, each of which is rechargeable with calcium and phosphate ions. The present invention also provides for a method of recharging the rechargeable dental material with calcium and phosphate ions.

Dental primer containing acid anhydride
10813848 · 2020-10-27 · ·

The present invention provides the dental primer for modifying surface of a dental restoration, comprising: an organic solvent, a silane coupling agent and an acid anhydride.

Dental polymerizable composition

A dental polymerizable composition including a glass powder and a (meth)acrylate is provided. The glass powder includes zinc, silicon, and fluorine and is substantially free of aluminum.

Dental polymerizable composition

A dental polymerizable composition including a glass powder and a (meth)acrylate is provided. The glass powder includes zinc, silicon, and fluorine and is substantially free of aluminum.

COMBINATION THERAPIES FOR TREATING CANCER

The present invention provides methods of treatment for recurrent cancer(s) through combination therapy with an agent that inhibits programmed death-1 protein (PD-1) signaling and an agent that inhibits poly [ADP-ribose] polymerase (PARP) signaling.

COMBINATION THERAPIES FOR TREATING CANCER

The present invention provides methods of treatment for recurrent cancer(s) through combination therapy with an agent that inhibits programmed death-1 protein (PD-1) signaling and an agent that inhibits poly [ADP-ribose] polymerase (PARP) signaling.

Oral care compositions containing potassium nitrate and peroxide

An oral care composition containing a gel phase, potassium nitrate, a peroxide source, an abrasive, and a fluoride source. Phase separation is not visually perceptible in the oral care composition.

Redox polymerizable composition with photolabile transition metal complexes

Polymerizable compositions comprising a redox initiator system is disclosed. The redox initiator system comprises a photolabile transition metal complex that photolyzes and initiates the redox cycle. Dental compositions comprising dental resins and the photolabile redox initiator system are also described.

Bondable microcapsules and surface functionalized fillers

A composition comprising microcapsules functionalized with polymerizable functional groups on the surface of said microcapsules wherein the functional groups form covalent bonds with monomers in the continuous phase to enhance the mechanical properties of the composition.